Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1228158 | 0.86 | — | — | |
| SCHEMBL5320376 | 0.81 | — | — | |
| SCHEMBL12126820 | 0.77 | — | — | |
| SCHEMBL8945562 | 0.77 | — | — | |
| SCHEMBL5324176 | 0.75 | — | — | |
| SCHEMBL16203196 | 0.73 | ACHE (0.33) | ACHE | |
| SCHEMBL10960567 | 0.73 | — | — | |
| SCHEMBL5710970 | 0.73 | — | — | |
| SCHEMBL7167428 | 0.73 | — | — | |
| SCHEMBL13757831 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3405501-B1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | ATEN PORUS LIFESCIENCES (IN) | 2023-11-15 | — | — | EP | disclosed |
| US-11447577-B2 | Cyclodextrin based polymers, methods, compositions and applications thereof | ATEN PORUS LIFESCIENCES (IN) | 2022-09-20 | — | — | US | disclosed |
| US-20210102006-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | ATEN PORUS LIFESCIENCES (IN) | 2021-04-08 | — | — | US | disclosed |
| WO-2018051298-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | ATEN PORUS LIFESCIENCES (IN) | 2018-03-22 | — | — | WO | disclosed |
| WO-2017125889-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | ATEN PORUS LIFESCIENCES (IN) | 2017-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210102006-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | CETP, NPC1L1, LIPA | ACHE 2355/4885POLB 4199/4885MAPK1 4070/4885 |
| US-11447577-B2 | Cyclodextrin based polymers, methods, compositions and applications thereof | CETP, NPC1L1, LIPA | ACHE 2355/4885POLB 4199/4885MAPK1 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.